CINECA IRIS Institutional Research Information System

ROMAGNOLI, Renato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.115
EU - Europa 8.272
AS - Asia 4.891
SA - Sud America 281
AF - Africa 122
OC - Oceania 93
Continente sconosciuto - Info sul continente non disponibili 17
Totale 26.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.880
CN - Cina 3.163
IT - Italia 2.127
IE - Irlanda 1.109
FR - Francia 856
SE - Svezia 724
DE - Germania 635
FI - Finlandia 480
UA - Ucraina 480
KR - Corea 437
AT - Austria 326
GB - Regno Unito 325
JP - Giappone 269
PL - Polonia 226
VN - Vietnam 213
IN - India 211
ES - Italia 177
CA - Canada 171
BE - Belgio 149
DK - Danimarca 147
BR - Brasile 122
TR - Turchia 121
NL - Olanda 120
TW - Taiwan 89
AU - Australia 84
HK - Hong Kong 79
RU - Federazione Russa 75
AR - Argentina 67
SG - Singapore 55
CH - Svizzera 54
MX - Messico 53
RO - Romania 47
PT - Portogallo 44
CO - Colombia 43
GR - Grecia 40
UZ - Uzbekistan 38
EG - Egitto 34
HU - Ungheria 30
PH - Filippine 30
TH - Thailandia 30
ID - Indonesia 27
IR - Iran 26
IL - Israele 22
KE - Kenya 22
PE - Perù 22
CZ - Repubblica Ceca 19
NO - Norvegia 19
SA - Arabia Saudita 19
HR - Croazia 17
EU - Europa 16
CL - Cile 14
MY - Malesia 13
SN - Senegal 10
BG - Bulgaria 9
NZ - Nuova Zelanda 9
ZM - Zambia 8
PK - Pakistan 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
IQ - Iraq 6
LB - Libano 6
RS - Serbia 6
SD - Sudan 6
VE - Venezuela 6
BA - Bosnia-Erzegovina 5
CM - Camerun 5
JO - Giordania 5
BF - Burkina Faso 4
LT - Lituania 4
MA - Marocco 4
MN - Mongolia 4
NG - Nigeria 4
NI - Nicaragua 4
SI - Slovenia 4
TN - Tunisia 4
BY - Bielorussia 3
CR - Costa Rica 3
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
MD - Moldavia 3
MM - Myanmar 3
MV - Maldive 3
MZ - Mozambico 3
SK - Slovacchia (Repubblica Slovacca) 3
GM - Gambi 2
LU - Lussemburgo 2
MK - Macedonia 2
NP - Nepal 2
SM - San Marino 2
SV - El Salvador 2
UG - Uganda 2
A1 - Anonimo 1
BD - Bangladesh 1
CU - Cuba 1
GT - Guatemala 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 26.786
Salva come PNG Salva come JPEG
Città #
Chandler 1.852
Beijing 1.496
Dublin 1.106
Ann Arbor 899
Fairfield 766
Houston 678
Villeurbanne 512
Torino 471
Ashburn 464
Princeton 448
Wilmington 428
Woodbridge 428
Dearborn 407
Medford 400
Jacksonville 372
Nyköping 351
Vienna 307
Cambridge 274
Redwood City 274
Seattle 269
New York 238
Warsaw 201
Pisa 185
Shanghai 179
Guangzhou 163
Turin 162
Hangzhou 142
Milan 139
Fremont 121
Dong Ket 113
Boston 103
Nanjing 98
Chengdu 85
Rome 82
Brussels 71
Boardman 70
Wuhan 58
Tokyo 57
Ottawa 56
Hefei 55
Barcelona 49
San Diego 49
Taipei 47
Hebei 46
Seoul 46
Kunming 45
San Mateo 44
Norwalk 42
Chongqing 40
Paris 39
Falls Church 38
London 38
Zhengzhou 37
Toronto 34
Berlin 33
Washington 32
Los Angeles 31
Fuzhou 29
Helsinki 29
Düsseldorf 28
Tianjin 28
Silver Spring 27
Changchun 26
Changsha 26
Delhi 26
Istanbul 26
Singapore 26
Upper Marlboro 26
Bologna 25
Mountain View 24
Padova 24
São Paulo 24
Jinan 23
Zurich 23
Rochester 22
Rotterdam 22
Verona 22
Buenos Aires 21
Duncan 21
Guiyang 21
Lima 20
Nanchang 20
Central 19
Chicago 19
Jakarta 19
Central District 18
Heidelberg 18
Madrid 18
Pittsburgh 18
Buffalo 17
Chennai 16
Hanover 16
Melbourne 16
Phoenix 16
San Francisco 16
Shenyang 16
Xian 16
Hanoi 15
Hong Kong 15
Malatya 15
Totale 16.182
Salva come PNG Salva come JPEG
Nome #
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 1.303
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 942
Human liver stem cells improve liver injury in a model of fulminant liver failure. 538
Liver graft preconditioning, preservation and reconditioning 504
Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. 473
Liver transplantation for aHUS: still needed in the eculizumab era? 419
Surgical management of post-cholecystectomy bile duct injuries: referral patterns and factors influencing early and long-term outcome 383
Early introduction of subcutaneous hepatitis B immunoglobulin following liver transplantation for hepatitis B virus infection: A prospective, multicenter study 369
Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials 359
Liver transplantation in severe methylmalonic acidemia: the sooner, the better 334
Simultaneous Liver-Kidney Transplantation in Adults: A Single-center Experience Comparing Results with Isolated Liver Transplantation 318
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis 300
Extracellular Vesicles from Human Liver Stem Cells Reduce Injury in an Ex Vivo Normothermic Hypoxic Rat Liver Perfusion Model 265
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 256
Surgical resection for hepatocellular carcinoma: moving from what can be done to what is worth doing 245
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication 231
Liver transplantation after severe hepatic trauma: a sustainable practice. A single-center experience and review of the literature 226
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 225
International comparison of liver transplant programmes: differences in indications, donor and recipient selection and outcome between Italy and UK 220
Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child with CD40 Ligand Deficiency and Cryptosporidium -Induced Liver Cirrhosis 193
Liver transplantation for symptomatic centrohepatic biliary cystadenoma 188
Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets 184
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant 184
Recellularization of rat liver scaffolds by human liver stem cells 181
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 163
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation 161
Human Liver Stem Cell-Derived Microvesicles Inhibit Hepatoma Growth in SCID Mice By Delivering Anti-tumor microRNAs. 159
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 155
Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction 155
RANK OF SURVIVAL BENEFIT, AS A PROPOSED PRIORITY SYSTEM, IN LIVER TRANSPLANT WAITING LIST: EVIDENCES FROM AN ITALIAN MULTICENTRE COHORT STUDY 151
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 151
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 147
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers 145
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 144
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 144
Human Liver Stem Cells Suppress T-Cell Proliferation, NK Activity, and Dendritic Cell Differentiation 143
Left-sided portal hypertension: successful management by laparoscopic splenectomy following splenic artery embolization. 141
The Angiogenic Potential of Adipose Mesenchymal Stem Cell-derived Extracellular Vesicles is modulated by Basic Fibroblast Growth Factor 141
PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia 140
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 140
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "Blended Principle Model" 135
Liver transplantation for “mass-forming” sclerosing cholangitis after laparoscopic cholecystectomy 130
Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period 130
Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration 130
Normothermic Machine Perfusion of Donor Livers Without the Need for Human Blood Products 129
Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency 126
Risk factors for metabolic syndrome after liver transplantation: what has changed over time 124
Graft factors as determinants of postoperative delirium after liver transplantation 120
SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE 115
Ansa digiunale ad Y secondo Roux e reflusso biliare 115
Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study 112
Liver transplantation with cavo-portal hemi-transposition: report of a case with venous pressure measurements 109
Hypothermic Oxygenated Machine Perfusion of Liver Grafts from Brain-Dead Donors 109
Posthepatectomy liver failure after simultaneous versus staged resection of colorectal cancer and synchronous hepatic metastases 107
ALL ORAL SOFOSBUVIR-BASED ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS AFFECTED BY MODERATE-SEVERE HEPATITIS C RECURRENCE: PREDICTORS OF VIRAL RESPONSE AND SURVIVAL 106
Centenarian Livers: Very Long-Term outcomes of very old grafts 105
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 104
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients 102
Carbapenemase Producing Klebsiella Pneumoniae Infection in Liver Transplant Recipients: Review of Our Experience 100
FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE 99
SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE 99
Porcine Isolated Liver Perfusion for the Study of Ischemia Reperfusion Injury: A Systematic Review. 99
Bilimetria esofago-gastrica delle 24 ore con BILITEC 2000 98
Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study 98
The effect of D-MELD on graft survival and course of HCV recurrence in HCV-RNA positive recipients after liver transplantation 96
Transplantation of the liver from a HBcAb positive donor into a HCV-RNA positive recipient adversely affects graft survival and worsens the course of HCV recurrence 94
“U-shaped” mesoportal jump graft to manage portal vein thrombosis during liver transplantation: A case report 94
Early liver transplantation for neonatal-onset methylmalonic acidemia 93
SOFOSBUVIR PLUS RIBAVIRIN FOR THE TREATMENT OF SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 93
Combined liver kidney transplantation for primary hyperoxaluria type 1: Will there still be a future? Current transplantation strategies and monocentric experience 92
www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH 91
Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA 91
NBAS mutations cause acute liver failure: When acetaminophen is not a culprit 90
Risk factors for arterial hypertension after liver transplantation 89
Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient 87
24-hour pH and bile monitoring of the denervated whole stomach as an esophageal substitute. 87
Radiotherapy treatment strategies for squamous cell carcinoma of the cervical oesophagus: Moving toward better outcomes 87
Antiviral Therapy With Sofosbuvir Plus Ribavirin Before Or Across Liver Transplantation To Prevent HCV Recurrence: Preliminary Data from a Single Centre Experience 87
The Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation. 86
Serological characterization of occult HBV infection in liver donors 86
LIVER TRANSPLANTATION IN PATIENTS WITH PREVIOUS NON-HODGKIN LYMPHOMA: REPORT OF A SINGLE CENTRE EXPERIENCE 84
ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE 84
Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection 84
Carrying on with liver transplantation during the COVID-19 emergency: Report from Piedmont region 84
DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY IN THE ASSESSMENT OF SIGNIFICANT LIVER FIBROSIS IN PAEDIATRIC LIVER TRANSPLANT RECIPIENTS 83
Peritoneal leukocytoclastic vasculitis as a cause of unexplained persistent ascites after liver transplantation 82
ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN DE-NOVO LIVER TRANSPLANTATION: A CASE MATCH ANALYSIS WITH TWICE-DAILY TACROLIMUS FORMULATION 82
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 82
Protective Effects of Human Liver Stem Cell-Derived Extracellular Vesicles in a Mouse Model of Hepatic Ischemia-Reperfusion Injury 82
LIVER GRAFT ISCHEMIC PRECONDITIONING: CLINICAL OUTCOMES 3 YEARS AFTER TRANSPLANTATION 81
SAFETY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY IMMEDIATELY AFTER LIVER TRANSPLANTATION: A MATCHED CASE-CONTROL ANALYSIS 81
Behind D-MELD: The Role of Primary Indication (HCV or HBV) as Significant Covariate in the Outcome Prediction after Liver Transplants 81
Vascular Remodeling of Visceral Arteries Following Interruption of the Splenic Artery During Liver Transplantation 81
Thromboelastogram changes in the perioperative period of adult living liver donation 78
MULTIMODAL TREATMENT OF HCC IN CIRRHOTIC LIVER, THE ROLE OF SURGERY. THE EXPERIENCE OF THE LIVER TRANSPLANT CENTRE OF TURIN 78
Successful urgent liver retransplantation for donor-transmitted hepatocellular carcinoma 78
DOES CROSSMATCH IMPACT LIVER TRANSPLANTATION OUTCOME? A SINGLE CENTER EXPERIENCE 78
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma 78
Liver transplantation with a partial graft is a risk factor for de novo tumors after transplant in the adult population 77
HCV infection and HLA-DRB1*11 in liver transplantation: a 15 years marriage 77
Totale 16.979
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.225
article - articoli 0
book - libri 0
conference - conferenze 22.532
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019729 0 0 0 0 0 0 0 0 0 0 474 255
2019/20203.818 171 131 156 412 277 679 455 273 374 355 274 261
2020/20213.230 319 218 199 165 252 197 319 281 281 292 264 443
2021/20224.382 208 197 237 301 366 311 287 283 182 354 784 872
2022/20235.883 705 474 179 522 435 1.386 442 431 574 174 353 208
2023/20242.611 432 479 187 199 239 473 160 142 72 211 17 0
Totale 28.135